ciprofloxacin has been researched along with clarithromycin in 243 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.23) | 18.7374 |
| 1990's | 63 (25.93) | 18.2507 |
| 2000's | 83 (34.16) | 29.6817 |
| 2010's | 76 (31.28) | 24.3611 |
| 2020's | 18 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Karlowsky, JA; Zhanel, GG | 1 |
| Beeton, ML; Chalker, VJ; Kotecha, S; Maxwell, NC; Spiller, OB | 1 |
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 1 |
| Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P | 1 |
| Gikas, A; Psaroulaki, A; Spyridaki, I; Tselentis, Y; Vranakis, I | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Hamasuna, R; Jensen, JS; Osada, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Mima, T; Schweizer, HP | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Biedenbach, DJ; Hammerschlag, MR; Jones, RN; Kohlhoff, SA; Roblin, PM | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Almayah, AA; Bolandnazar, Z; Ebrahimi, A; Ebrahimi, HP; Hadi, JS; Swadi, AG | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kimmins, S; Mutak, S; Pavlović, D | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M | 1 |
| Bi, F; Cai, X; Gu, X; Hu, C; Liu, Z; Ma, S; Song, D; Venter, H; Zhang, N | 1 |
| Cushman, M; Fan, BZ; Han, X; Kong, FS; Li, YX; Liang, JH; Lv, W; Ma, CX; Tian, JC | 1 |
| Cushman, M; Fan, BZ; Guo, SY; Kong, FS; Li, XM; Li, YX; Liang, JH; Lv, W; Zhang, J | 1 |
| Aldrich, C; Brody, S; Cushman, M; Fan, BZ; Hiasa, H; Liang, JH; Lv, W; Yang, ZY | 1 |
| Bi, F; Liu, X; Ma, S; Qin, Y; Song, D; Teng, Y; Zhang, N | 1 |
| Cushman, M; Ding, J; Li, Y; Liang, JH; Liu, LY; Liu, XP; Lv, W; Xue, F; Zhang, JR; Zhang, JZ; Zhao, F | 1 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
| De Gregoris, P; Fattorini, L; Hu, CQ; Iona, E; Mascellino, MT; Orefici, G; Santoro, C | 1 |
| Allen, W; Gorzynski, EA; Gutman, SI | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Liebers, DM; Smith, RP | 1 |
| Kapell, KS; Kessler, HA; Segreti, J; Trenholme, GM | 1 |
| Forslund, T; Katila, ML; Kousa, M; Krees, R; Relander, A; Rummukainen, M | 1 |
| Kobayashi, N; Negishi, T; Yoshida, K | 1 |
| Dhoore, F; Verbist, L | 1 |
| Feiner, CM; Spiegl, PV | 1 |
| Hirose, T; Kumamoto, Y; Nishimura, M; Ohya, S; Sano, M | 1 |
| Allen, NB; Corey, GR; Darling, TN; Kamino, H; Murray, JC; Sidhu-Malik, N | 1 |
| Bartholomew, W; Goldstein, E; Klotz, SA; Zahid, MA | 1 |
| Dusart, G; Simeon De Buochberg, M; Ximenes, E; Zuccarelli, M | 1 |
| Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R | 1 |
| Ikerd, TR; Koletar, SL | 1 |
| Hjelm, U; Hoffner, SE; Källenius, G | 1 |
| Clark, JA; Margolis, DM | 1 |
| Atkinson, BA; Bocanegra, R; Graybill, JR | 1 |
| Asnis, DS; Bresciani, AR; Cohn, M | 1 |
| Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
| Conte, JE; Duncan, S; Golden, J; Lin, E; McKenna, E; Zurlinden, E | 1 |
| Climo, MW; Gillum, JG; Israel, DS; Polk, RE; Scott, RB | 1 |
| Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
| Beyer, J; Clement, J; Flamm, RK; Tanaka, SK | 1 |
| de'Clari, F | 1 |
| Flisch, CW; Santa, DD; Zuber, C | 1 |
| Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| Davies, BI; Dirks-Go, SI; Hoogkamp-Korstanje, JA; Kabel, P; Manson, WL; Stobberingh, EE; Vreede, RW | 1 |
| de la Viuda, JM; Díaz, F; Mendoza, F; Urkijo, JC | 1 |
| Andrews, JM; Boswell, F; Brenwald, NP; Wise, R | 1 |
| Hirose, T; Kobayashi, Y; Kumamoto, Y; Nishimura, M; Sano, M; Takahashi, S; Tsukamoto, T | 1 |
| Fuursted, K | 1 |
| Barbarini, D; Bono, L; Carretto, E; Marone, P; Telecco, S | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Muszynski, MJ; Rajyaguru, JM | 1 |
| Brancato, R; Carones, F; Cavallero, A; Gesu, G; Venturi, E | 1 |
| Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC | 2 |
| Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
| Butt, AA | 1 |
| Popov, VL; Reisner, BS; Woods, GL | 1 |
| Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
| Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK | 1 |
| Fischer, BP; Hahn, EG; Müller, A; Schneider, HT; Strauss, R | 1 |
| Carton, AT; Kerawala, CJ; Makhani, S; Postlethwaite, KR; Renny, NM | 1 |
| Barzilai, A; Blank-Porat, D; Keller, N; Levi, I; Rubinovich, B; Rubinstein, E | 1 |
| Gikas, A; Kofterithis, D; Psaroulaki, A; Spyridaki, I; Tselentis, Y | 1 |
| Bouchillon, S; Johnson, J; Pontani, D; Washton, H | 1 |
| Badiaga, S; Brouqui, P; Debat Zoguereh, D; Niang, M | 1 |
| Anzueto, A; Barkman, HW; Chodosh, S; Kowalsky, S; Moesker, H; Schreurs, A; Shan, M; Siami, G; Stack, T | 1 |
| Ansorg, R; Fabry, W; Schmid, EN | 1 |
| Kerharo, G; Matsiota-Bernard, P; Nauciel, C; Vrioni, G | 1 |
| Allerberger, F; Hasse, J; Miglioli, PA; Walderberg, I | 1 |
| Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
| Dubois, J; St-Pierre, C | 1 |
| Clifford, K; Echols, RM; Heyd, A; Huck, W; Shan, M; Tosiello, R | 1 |
| Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Hirose, T; Hotta, H; Itoh, N; Kumamoto, Y; Matsukawa, M; Sano, M; Takahashi, S; Tsukamoto, T | 1 |
| Dart, JK; Horgan, SE; Matheson, MM; McLOUGHLIN-Borlace, L | 1 |
| Anzueto, A; Grossman, RF; Rizzo, JA | 1 |
| Koromihis, G; Libman, M; MacLean, JD; Semret, M; Ward, BJ | 1 |
| Keiser, P; Nassar, N; Rademacher, S; Skiest, D; Smith, JW | 1 |
| Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
| Boyanova, L; Katzarov, N; Koumanova, R; Mitov, I; Spassova, Z; Stancheva, I | 1 |
| Auckenthaler, R; Ninet, B; Pechère, M; Rohner, P; Saurat, JH; Toutous-Trellu, L | 1 |
| Beck, D; Heep, M; Kist, M; Lehn, N; Strobel, S | 1 |
| Alfa, M; Harding, G; Kabani, A; Thibert, L; Turenne, C; Wolfe, J | 1 |
| Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Bañuls, J; Betlloch, I; Botella, R; Navas, J; Pascual, E; Ramón, R | 1 |
| Jiang, Q; Taylor, DE; Wang, G; Wilson, TJ | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Carabias, ML; Cervera, LA; entelles, ML; García-Navas, BL | 1 |
| Abouesh, A; Hobbs, WR; Stone, C | 1 |
| Kanemitsu, K; Kunishima, H; Shimada, J; Takemura, H; Yamamoto, H | 1 |
| Báñez, F; Biechy, M; Gálvez, E; Salgueró, E | 1 |
| Böcher, W; Galle, PR; Märker-Hermann, E | 1 |
| Huth, RG; Jahn, B; Kamin, W; Knuf, M; Meyer, HG; Trübel, HK | 1 |
| Bózsik, BP | 1 |
| Amat, C; Ancelin-Malbreil, E; Becquart, JP; Faulques, B; Michault, A; Picot, S; Sapin, G; Simac, C | 1 |
| Al-Mobeireek, AF | 1 |
| Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K | 1 |
| Ahrén, IL; Forsgren, A; Karlsson, E; Riesbeck, K | 1 |
| Cui, L; Feng, X; Guan, X; Wang, H; Zhao, G | 1 |
| Blum, S; Sauter, C | 1 |
| Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Kusaba, N; Yoshida, H | 1 |
| Daines, BS; Sandoval, HP; Solomon, KD; Steed, LL; Vroman, DT | 1 |
| Ayyagari, A; Bhasin, D; Das, BK; Dharmalingam, S; Habibullah, CM; Khan, AA; Naik, SR; Rajasambandam, P; Ramathilagam, B; Rao, UA; Ray, P; Sharma, MP; Thyagarajan, SP | 1 |
| Babinchak, TJ; Desimone, JA; Kaulback, KR; Pomerantz, RJ | 1 |
| Dick, JD; Hose, S; Hyon, JY; Joo, MJ; O'Brien, TP; Sinha, D | 1 |
| Aish, L; Gaur, S; Trayner, E; Weinstein, R | 1 |
| Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A | 1 |
| Cattier, B; Hajjaji, N; Lanotte, P; Legras, A; Perrotin, D | 1 |
| Giangaspro, E; González Tomé, MI; Palenque, E; Ramos Amador, JT; Sánchez Granados, JM; Sanz Santaeufemia, FJ | 1 |
| Jeyaratnam, D; Keenan, N; Sheerin, NS | 1 |
| Galley, HF; Watt, AM; Webster, NR; Williams, AC | 1 |
| Barten, M; Bittner, HB; Bossert, T; Gummert, JF; Mohr, FW; Rahmel, A; Richter, M | 1 |
| Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
| Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
| Brook, I; Elliott, TB; Germana, A; Giraldo, DE; Jackson, WE; Ledney, GD; Nicolau, DP; Shoemaker, MO; Thakar, JH | 1 |
| El-Afify, DR; El-Maghraby, GM; Hedaya, MA | 1 |
| Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
| Jackson, MA; Selvarangan, R; Sharma, M; Thorell, EA; Woods, GM | 1 |
| Altraja, A; Kullamaa, A; Leesik, H; Meriste, S; Naaber, P; Tamm, E | 1 |
| Bermúdez-Ruiz, P; de la Quintana-Beltrán, P; Pérez de Pedro, I | 1 |
| Falagas, ME; Kolia, MD; Korres, DS; Papagelopoulos, PJ; Poulakou, GG; Zahos, KA | 1 |
| Cefalo, E; Cugliari, M; Martín, M; Valerga, M | 1 |
| Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA | 1 |
| Chen, CC; Chen, SY; Chen, YS; Cheng, PW; Lo, CY | 1 |
| Bai, GH; Chang, CL; Jeong, J; Kim, Jm; Lee, EY; Lee, MK; Lee, SM; Park, YK | 1 |
| Banks, J; Campbell, IA; Gelder, CM; Jenkins, PA; Prescott, RJ; Smith, AP | 1 |
| Hill, AT; Laurenson, IF; Murray, MP | 1 |
| Gopinath, K; Sankar, MM; Singh, S; Singla, R | 1 |
| Akamine, M; Atsumi, E; Baba, M; Fujita, J; Furugen, M; Haranaga, S; Higa, F; Koide, M; Naha, Y; Sato, Y; Tamayose, M; Tateyama, M; Teruya, H; Uchihara, T; Yara, S | 1 |
| Ando, S; Inoue, M; Kishimoto, T; Ogawa, M; Sato, K; Takemura, H; Yamazaki, T | 1 |
| Booth, F; Gottlieb, T; Janarthanan, P; Karim, R; McCarthy, S; Merani, R; Orekondy, S | 1 |
| Cedidi, C; Dabernig, J; Ingianni, G; Nenadic, I; Schumacher, O | 1 |
| Chang, SL; Chung, WH; Hong, HS; Huang, YH | 1 |
| Arigbabu, AO; Coker, AO; Oyedeji, KS; Smith, SI | 1 |
| Iwatsuki, K; Kobayashi, T; Wakabayashi, H; Yaeshima, T; Yamauchi, K; Yoshie, H | 1 |
| Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
| Boehler, A; Gaspert, A; Irani, S; Lienhardt, B; Weishaupt, D | 1 |
| Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK | 1 |
| Chang, CL; Choi, GE; Kang, JE; Kim, JM; Kim, KH; Lee, EY; Tateda, K; Yamaguchi, K | 1 |
| Azevedo, F; Baudrier, T; Duarte, AF; Ferreira, O; Mota, A; Simões, JS | 1 |
| Feliciano, O; Fernández, H; Gala, A; Gutiérrez, O; Guzmán, D; Kobayashi, N; Llanes, R; Llop, A; Nagashima, S; Soria, C; Valdés, L; Wada, A | 1 |
| Kekulé, AS; Kreft, B; Lübbert, C; Marsch, WC; Oehme, A | 1 |
| Abensur, H; Araújo, MR; Castro-Silva, AN; Elmor de Araújo, MR; Freire, AO; Grinbaum, RS; Noronha, IL; Romão, JE; Sampaio, JL | 1 |
| Hsueh, PR; Lee, PI; Yang, JC | 1 |
| Alonso-Rodríguez, N; Esteban, J; Fernández-Roblas, R; Martín-de-Hijas, N; Molina-Manso, D; Ortíz-Pérez, A | 1 |
| Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
| Benoliel, J; Cabral, J; Lemos, PS; Lopes, AI; Oleastro, M; Paixão, E; Ramalho, PM; Santos, A | 1 |
| Choi, KD; Chung, JW; Jeong, JY; Jung, HY; Jung, JH; Kim, JH; Lee, GH; Lee, SM; Song, HJ | 1 |
| Duchin, JS; Kay, MK; Perti, TR | 1 |
| Ahn, J; Jeon, K; Kang, H; Kim, HS; Koh, WJ; Lee, EJ; Lee, KS | 1 |
| Bircher, AJ; Brož, P; Grize, L; Harr, T; Hecking, C; Jaeger, KA; Scherer, K | 1 |
| Fox, JG; Kawamura, Y; Matsui, M; Mori, S; Rimbara, E; Shen, Z; Shibayama, K; Suzuki, S; Wachino, J | 1 |
| Andersen, LP; Berg, D; Jonaitis, L; Jørgensen, M; Kadusevicius, E; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Miciuleviciene, J; Rasmussen, L; Tamosiunas, V; Urbonaviciene, N | 1 |
| Kale-Pradhan, PB; Palmer, JR; Wilhelm, SM; Zhao, JJ | 1 |
| Kim, H; Matsui, M; Mori, S; Mukai, M; Rimbara, E; Shibayama, K; Suzuki, S; Takahashi, S; Yamamoto, S | 1 |
| Cai, L; Li, CY; Liu, ZH; Sun, ZG; Zhang, JZ; Zhou, C; Zhuo, FL | 1 |
| Lally, L; Mannion, L | 1 |
| Athan, E; Callan, P; Friedman, ND; Hughes, AJ; Khajehnoori, M; McDonald, A; O'Brien, DP; Rahdon, R | 1 |
| Chang, SE; Choi, JH; Lee, MW; Lee, SO; Noh, TK; Won, CH | 1 |
| Mihçiokur, H; Oğuz, M | 1 |
| Hunter-Ellul, LA; Martin, JE; Philips, RC; Wilkerson, MG | 1 |
| Patsche, CB; Svensson, E; Wejse, C | 1 |
| Elkhatib, W; Noreddin, A | 1 |
| Goodwin, JS; Kuo, YF; Lin, YL; Parekh, TM; Raji, M; Tan, A | 1 |
| Cañas-Hernandez, F; de Miguel-Martinez, I; Lorenzo-Garde, L | 1 |
| Chan, KA; Chang, CH; Chou, HW; Lai, CL; Lai, MS; Wang, JL | 1 |
| Athan, E; Callan, P; Cowan, R; Friedman, ND; Fyfe, J; Hughes, AJ; McDonald, A; O'Brien, DP | 1 |
| Al-Adhba, HS; Ben Chaabane, N | 1 |
| Antony, SJ | 1 |
| Esteban, J; García-Pedrazuela, M; Mahillo-Fernandez, I; Muñoz-Egea, MC | 1 |
| Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
| Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A | 1 |
| Dubini, M; Marraccini, P; Pignatti, P | 1 |
| Büchsel, M; Fleiner, M; Häcker, G; Pletschen, L; Serr, A | 1 |
| Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
| Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N | 1 |
| Baluch, A; Pasikhova, Y; Snyder, M | 1 |
| Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N | 1 |
| Bodík, I; Fáberová, M; Grabic, R; Ivanová, L; Mackuľak, T | 1 |
| Gu, L; Li, R; Liu, Y; Qu, J; Wang, P; Wei, M; Yang, C | 1 |
| Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
| Mohamed Fuad, Z; Mohd Yusof, NH; Periasamy, P; Shaharir, SS; Sulaiman Sahari, N; Sulong, A; Zukiman, WZHW | 1 |
| Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
| Fabiánová, K; Jakubů, V; Urbášková, P; Zavadilová, J | 1 |
| Chen, S; Li, X; Quan, X; Wang, S; Yu, H; Zhao, H | 1 |
| Catão-Dias, JL; da Silva, VMF; Ferreira Neto, JS; Ikuta, CY; Ippolito, L; Neto, JA; Reisfeld, L; Rosas, FCW; Silvatti, B | 1 |
| Allem, R; Bachir, M; Benejat, L; Douidi, KT; Drici, AE; Medjekane, M; Megraud, F; Tifrit, A | 1 |
| Aderemi, AO; Alves, LM; Hunter, C; Lemos, MFL; Novais, SC; Pahl, O | 1 |
| Bayingana, C; Dusabejambo, V; Hale, D; Hategeka, C; Kabakambira, JD; Ndoli, J; Ngabonziza, F; Ntirenganya, C; Page, C; Walker, T | 1 |
| Almeida da Silva, PE; Bierhals, D; Lourenço, MC; Ramis, IB; Ramos, DF; Vianna, JS; Viveiros, M; von Groll, A; Zanatta, N | 1 |
| Abebe, W; Moges, F; Molla, R; Tiruneh, M | 1 |
| Chaozer, E; Kuthiah, N | 1 |
| Alebouyeh, M; Amirmozafari, N; Bayati, S; Ebrahimi Daryani, N; Talebi, M; Zali, MR | 1 |
| Giebułtowicz, J; Harnisz, M; Korzeniewska, E; Kucharski, D; Nałęcz-Jawecki, G; Płaza, G | 1 |
| Constantine, SR; Dissanayaka, BS; Gunasekera, CN; Guruge, C; Herath, HMMTB; Jinadasa, GIM; Keragala, BSDP; Liyanagama, DP; Yesudian, PD | 1 |
| Begbey, A; Guppy, JH; Mohan, C; Webster, S | 1 |
| Guo, Y; Wan, B; Wang, H; Wang, W; Wu, X; Yang, J; Yu, F | 1 |
| Álvarez-Rodríguez, E; Arias-Estévez, M; Cela-Dablanca, R; Fernández-Calviño, D; Núñez-Delgado, A; Rodríguez-López, L | 1 |
| Barceló, D; Borja, Á; de Alda, ML; Larreta, J; López-García, E; Postigo, C; Rodríguez, JG; Solaun, O; Zonja, B | 1 |
| Catherine Stanton, I; Hayes, A; Hugo Gaze, W; Kaye Murray, A; May Murray, L; Snape, J; Zhang, L | 1 |
| Bai, B; Chang, X; Chen, W; Gu, X; Guo, T; Ma, S; Wang, Y; Zhang, P; Zhang, S | 1 |
| Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
| Álvarez-Rodríguez, E; Arias-Estévez, M; Díaz-Raviña, M; Fernández-Calviño, D; Núñez-Delgado, A; Rodríguez-González, L; Santás-Miguel, V | 1 |
| Aydiner, C; Ikizoglu, B; Kanat, G; Turkdogan, FI | 1 |
| Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
| Mıhçıokur, H; Osman, D; Özkan, O; Uyanık, İ | 1 |
| Chasqueira, MJ; Cruz, C; Fernandes, F; Paixão, P; Rodrigues, L; Santos, R | 1 |
7 review(s) available for ciprofloxacin and clarithromycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[A case of arthritis of the wrist caused by Mycobacterium marinum. Review of the literature].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Arthritis, Infectious; Ciprofloxacin; Clarithromycin; Debridement; Drug Therapy, Combination; Female; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Wrist Joint | 1996 |
[Cat-scratch disease. A report of 4 cases and a review of the literature].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Bartonella henselae; Cat-Scratch Disease; Ciprofloxacin; Clarithromycin; Humans; Male; Middle Aged; Time Factors | 1997 |
Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drainage; Drug Therapy, Combination; Humans; Lymphadenitis; Male; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Tomography, X-Ray Computed | 1998 |
Antimicrobial-induced mania (antibiomania): a review of spontaneous reports.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Bipolar Disorder; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Risk Factors; United States; United States Food and Drug Administration | 2002 |
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Indicators and Reagents; Keratomileusis, Laser In Situ; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Postoperative Complications; Staining and Labeling; Tobramycin | 2003 |
The role of antimicrobials in Crohn's disease.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Crohn Disease; Humans; Metronidazole; Remission Induction; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome | 2013 |
13 trial(s) available for ciprofloxacin and clarithromycin
| Article | Year |
|---|---|
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Humans; Male; Theophylline | 1996 |
[A clinical study on combination therapy of antimicrobial agents for complicated urinary tract infection--with special reference to combination with clarithromycin].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Middle Aged; Urinary Tract Infections | 1997 |
Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Clarithromycin; Consumer Product Safety; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 1998 |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1999 |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome | 1999 |
Biofilm in complicated urinary tract infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Middle Aged; Urinary Catheterization; Urinary Tract Infections | 1999 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
Three cases of cutaneous sarcoidosis: search for bacterial agent by the 16S RNA gene analysis and treatment with antibiotics.
Topics: Adult; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Female; Humans; Middle Aged; Pilot Projects; Prospective Studies; RNA, Ribosomal, 16S; Sarcoidosis; Skin; Skin Diseases; Treatment Outcome | 2000 |
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunotherapy; Male; Middle Aged; Opportunistic Infections; Rifampin; Tuberculosis, Pulmonary | 2008 |
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Treatment Outcome; Young Adult | 2015 |
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Disease Eradication; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Rwanda; Treatment Failure | 2018 |
223 other study(ies) available for ciprofloxacin and clarithromycin
| Article | Year |
|---|---|
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae.
Topics: Bacteremia; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory System; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Species Specificity; Tetracycline; Ureaplasma; Ureaplasma Infections | 2009 |
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Comparative antipneumococcal activities of sulopenem and other drugs.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2009 |
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Coxiella burnetii; Humans; Microbial Sensitivity Tests; Minocycline; Q Fever; Tigecycline; Vero Cells | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
Topics: Microbial Sensitivity Tests; Mycoplasma genitalium; Polymerase Chain Reaction | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Fusidic Acid; Neisseria gonorrhoeae | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Metal-based biologically active azoles and β-lactams derived from sulfa drugs.
Topics: Anti-Bacterial Agents; Azoles; Bacteria; Bacterial Infections; beta-Lactams; Coordination Complexes; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Schiff Bases; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles | 2016 |
Synthesis of novel 15-membered 8a-azahomoerythromycin A acylides: Consequences of structural modification at the C-3 and C-6 position on antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Structure-Activity Relationship | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones | 2017 |
Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators.
Topics: Anti-Bacterial Agents; Bacillus pumilus; Bacillus subtilis; Bacterial Proteins; Benzamides; Cell Survival; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Drug Design; HeLa Cells; Humans; Isoxazoles; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Ketolides; Microbial Sensitivity Tests; Molecular Structure; Oximes; Quinolones; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2019 |
Synthesis and structure-bactericidal activity relationships of non-ketolides: 9-Oxime clarithromycin 11,12-cyclic carbonate featured with three-to eight-atom-length spacers at 3-OH.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2019 |
Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
Topics: Anti-Bacterial Agents; Azithromycin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |
Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Binding Sites; Cell Survival; Cytoskeletal Proteins; Drug Design; Drug Resistance, Bacterial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Isoxazoles; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Structure-Activity Relationship | 2020 |
Design and synthesis of novel macrolones bridged with linkers from 11,12-positions of macrolides.
Topics: Anti-Bacterial Agents; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Quinolones; Structure-Activity Relationship | 2022 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects | 1992 |
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins | 1991 |
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Radiometry | 1991 |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Enoxacin; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Pefloxacin; Quinolones | 1989 |
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Enoxacin; Erythromycin; Imipenem; Legionella; Leucomycins; Microbial Sensitivity Tests; Rifampin | 1989 |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Combinations; Erythromycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Disseminated cutaneous infection due to Mycobacterium chelonae in a patient with rheumatoid arthritis, amyloidosis, and renal failure.
Topics: Amyloidosis; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Rheumatoid; Biopsy; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections; Skin; Skin Diseases | 1995 |
Chlamydia trachomatis infection in the semen of asymptomatic infertile men: detection of the antigen by in situ hybridization.
Topics: Adult; Antibodies, Bacterial; Antigens, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clarithromycin; Humans; Immunoglobulin A; In Situ Hybridization; Infertility, Male; Leukocyte Elastase; Male; Middle Aged; Pancreatic Elastase; Semen; Ureaplasma Infections; Ureaplasma urealyticum | 1994 |
In vitro susceptibility of recently isolated respiratory tract pathogens to minocycline and comparable antibiotics. A multicentre study.
Topics: Adult; Amoxicillin; Bacteria; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acids; Doxycycline; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Minocycline; Moraxella catarrhalis; Respiratory System; Streptococcus pneumoniae | 1994 |
Mycobacterium phlei infection of the foot: a case report.
Topics: Biopsy; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Foot Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections; Mycobacterium phlei | 1994 |
[Therapeutic study on biofilm of the urinary tract using a severely complicated bladder model (biofilm model of the urinary tract)--experimental study using an automatic simulator of urinary antimicrobial agent concentration, and clinical study].
Topics: Ciprofloxacin; Clarithromycin; Colloids; Drug Administration Schedule; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Models, Biological; Polyesters; Pseudomonas aeruginosa; Urinary Tract Infections | 1994 |
Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin.
Topics: Aged; Arthritis, Rheumatoid; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections, Nontuberculous; Prednisone; Rifampin; Skin; Vasculitis | 1994 |
Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
Topics: Aged; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 1994 |
[Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria].
Topics: Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Mycobacterium phlei; Nontuberculous Mycobacteria; Rifampin | 1993 |
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin | 1993 |
In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Fluoroquinolones; Giardia lamblia; Metronidazole; Microbial Sensitivity Tests; Quinolones | 1993 |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Skin Diseases, Bacterial | 1993 |
Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Mycobacterium haemophilum; Mycobacterium Infections; Rifabutin | 1995 |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin | 1996 |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Epithelium; Female; Humans; Male; Pulmonary Alveoli | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Kill kinetics of antimicrobial agents against Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Helicobacter pylori; Humans; Kinetics; Logistic Models; Metronidazole; Microbial Sensitivity Tests; Organometallic Compounds | 1996 |
Ciprofloxacin was the culprit--not itraconazole.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bronchodilator Agents; Central Nervous System; Ciprofloxacin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Humans; Itraconazole; Theophylline; Time Factors | 1997 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Clavulanic Acids; Drug Evaluation; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Quinolones; Streptococcus pneumoniae | 1997 |
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteroides fragilis; Chlamydia; Ciprofloxacin; Clarithromycin; Doxycycline; Enterobacter; Erythromycin; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae | 1997 |
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
Topics: Amikacin; Antitubercular Agents; Cell Division; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Radiometry; Rifampin | 1997 |
Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
Topics: Acquired Immunodeficiency Syndrome; Agar; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Fluoroimmunoassay; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Nucleic Acid Hybridization; Rifabutin | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae | 1997 |
Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
Topics: 1-Naphthylamine; Anti-Infective Agents; Azithromycin; Bacterial Outer Membrane Proteins; Burkholderia cepacia; Cations; Ceftazidime; Cell Membrane Permeability; Ciprofloxacin; Clarithromycin; Fleroxacin; Fluorescent Dyes; Fluoroquinolones; Gentamicins; Magnesium; Microbial Sensitivity Tests; Microscopy, Electron; Novobiocin; Oxolinic Acid; Polysaccharides, Bacterial; Tobramycin | 1997 |
Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Follow-Up Studies; Humans; Lasers, Excimer; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Photorefractive Keratectomy; Postoperative Complications; Visual Acuity; Wound Healing | 1997 |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Legionella; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1997 |
Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin.
Topics: Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
[Tsutsugamushi fever. Rare rickettsiosis after a stay in the Philippines].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Doxycycline; Fever; Germany; Humans; Lung; Male; Orientia tsutsugamushi; Philippines; Radiography; Scrub Typhus; Travel | 1998 |
Atypical cervico-facial mycobacterial infections in childhood.
Topics: Algorithms; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Drug Combinations; Face; Female; Humans; Lymph Node Excision; Lymphadenitis; Mycobacterium Infections, Nontuberculous; Neck; Nontuberculous Mycobacteria; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Disease-Free Survival; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Retrospective Studies; Treatment Outcome | 1998 |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
Topics: Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Coxiella burnetii; Doxycycline; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin | 1998 |
Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Pseudomonas aeruginosa; Respiratory System; Staphylococcus aureus; Streptococcus pneumoniae | 1998 |
[Painful nodular lesions].
Topics: Adult; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Lymph Nodes; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Pain; Skin Diseases, Bacterial | 1998 |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Fleroxacin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Mice; Mice, Inbred C57BL; Mycobacterium; Mycobacterium Infections; Rifabutin; Spleen | 1998 |
Antibacterial activity of human pleural fluid: alone and in combination with antibiotics.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Escherichia coli; Gentamicins; Humans; Immunity, Innate; Meropenem; Microbial Sensitivity Tests; Middle Aged; Paraneoplastic Syndromes; Pleural Effusion, Malignant; Proteus; Staphylococcus aureus; Thienamycins | 1998 |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Gatifloxacin; Legionella; Microbial Sensitivity Tests; Rifampin | 1999 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Culture Media; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Propionibacterium acnes; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1999 |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; Time Factors | 1999 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Cloxacillin; Ethambutol; Humans; Leg Ulcer; Male; Metronidazole; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Penicillins; Rifampin; Skin Diseases, Bacterial; Skin Transplantation; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence | 1999 |
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; CD4 Lymphocyte Count; Ciprofloxacin; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Longitudinal Studies; Male; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors | 1999 |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Stomach; Tetracycline | 2000 |
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy.
Topics: Amoxicillin; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2000 |
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Clarithromycin; DNA, Ribosomal; Drug Therapy, Combination; Female; Hand; Humans; Lung Diseases; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycolic Acids; RNA, Ribosomal, 16S; Skin Diseases, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Dermatomyositis; Drug Resistance, Microbial; Female; Humans; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 2000 |
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Transformation, Bacterial | 2001 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance; Fluoroquinolones; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Naphthyridines; Nasopharynx; Neisseria meningitidis; Respiratory Tract Infections; Rifampin; Time Factors | 2001 |
Evaluation of the activity of antimicrobial agents against Legionella pneumophila multiplying in a human monocytic cell line, THP-1, and an alveolar epithelial cell line, A549.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cell Line; Ciprofloxacin; Clarithromycin; Erythromycin; Humans; Legionella pneumophila; Macrophages; Microbial Sensitivity Tests; Respiratory Mucosa | 2000 |
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis].
Topics: Abscess; Actinomycetales Infections; Adrenal Cortex Hormones; Aged; Amikacin; Anti-Glomerular Basement Membrane Disease; Ciprofloxacin; Clarithromycin; Cyclophosphamide; Disease Susceptibility; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Opportunistic Infections; Pneumonia, Bacterial; Renal Dialysis; Rhodococcus equi; Thigh | 2001 |
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Biopsy; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Extremities; Glucocorticoids; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Prednisolone; Skin Diseases, Bacterial; Skin Ulcer; Vasculitis | 2002 |
Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Male; Nutrition Disorders; Pneumonia, Bacterial | 2002 |
[Comment on Borrelia burgdorferi Group infections].
Topics: Antibodies, Bacterial; Borrelia burgdorferi Group; Ceftriaxone; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Humans; Josamycin; Lyme Disease | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clarithromycin; Confidence Intervals; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Random Amplified Polymorphic DNA Technique; Reunion; Stomach Ulcer; Tetracycline; Treatment Failure | 2002 |
Rapidly growing mycobacterial pulmonary infection in association with severe gastroesophageal reflux disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Gastroesophageal Reflux; Hernia, Hiatal; Humans; Male; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Data Collection; Drug Therapy, Combination; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Vancomycin | 2002 |
Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Clarithromycin; Haemophilus influenzae; Humans; Intracellular Fluid; Ketolides; Macrolides; Microbial Sensitivity Tests; Tumor Cells, Cultured; Virginiamycin | 2002 |
[Interaction between biofilm formed by Pseudomonas aeruginosa and antibacterial agents].
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clarithromycin; Drug Synergism; Pseudomonas aeruginosa; Roxithromycin | 2000 |
Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Female; Hodgkin Disease; Humans; Lung Neoplasms; Reed-Sternberg Cells | 2003 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
[Cat scratch disease].
Topics: Animals; Azithromycin; Bartonella henselae; Cat-Scratch Disease; Cats; Ciprofloxacin; Clarithromycin; Humans; Insect Vectors; Serologic Tests; Siphonaptera; Zoonoses | 2003 |
Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; India; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2003 |
Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Ciprofloxacin; Clarithromycin; Decision Trees; Diagnosis, Differential; HIV-1; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography | 2003 |
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits | 2004 |
Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection.
Topics: Aged; Anti-Infective Agents; Bronchial Neoplasms; Bronchiectasis; Chronic Disease; Ciprofloxacin; Clarithromycin; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell; Mycobacterium avium; Tuberculosis | 2004 |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors | 2005 |
[Mycobacterium chelonae myositis].
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Arthritis, Rheumatoid; Ciprofloxacin; Clarithromycin; Humans; Immunocompromised Host; Leg; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myositis; Vasculitis | 2004 |
[Usefulness of chemotherapy associated with surgery in the management of nontuberculous mycobacterial adenitis].
Topics: Child, Preschool; Ciprofloxacin; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Infant; Lymphadenitis; Male; Mycobacterium Infections, Nontuberculous; Retrospective Studies | 2005 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Equipment Contamination; Gentamicins; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Mycobacterium; Mycobacterium Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pneumonia, Pneumocystis; Renal Dialysis; Rifabutin; Vancomycin | 2005 |
Differential effects of three antibiotics on T helper cell cytokine expression.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Cells, Cultured; Ciprofloxacin; Clarithromycin; Cytokines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Interferon-gamma; Interleukin-4; Ionomycin; Lymphocyte Activation; Male; Middle Aged; Moxifloxacin; Quinolines; T-Lymphocytes, Helper-Inducer; Tetradecanoylphorbol Acetate; Th1 Cells; Th2 Cells | 2005 |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Mycobacterium xenopi; Postoperative Complications; Tuberculosis, Pulmonary | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
Comparison of clarithromycin and ciprofloxacin therapy for Bacillus anthracis Sterne infection in mice with or without (60)Co gamma-photon irradiation.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cobalt; Drug Therapy, Combination; Female; Gamma Rays; Mice | 2005 |
The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Liver; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2006 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Linezolid; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections; Oxazolidinones; Treatment Outcome | 2006 |
Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Estonia; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2006 |
[Cervical lymphadenitis due to Mycobacterium avium in an immunocompetent adult].
Topics: Accidents, Traffic; Adolescent; Ciprofloxacin; Clarithromycin; Ethambutol; Humans; Immunocompetence; Lymphadenitis; Male; Mouth; Mycobacterium avium-intracellulare Infection; Neck; Wound Infection | 2007 |
Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient.
Topics: Anti-Infective Agents; Cervical Vertebrae; Ciprofloxacin; Clarithromycin; Discitis; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Kyphosis; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Postoperative Complications; Risk Factors; Tuberculosis, Spinal | 2007 |
[Mycobacterium avium infection in a renal transplant recipient].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Ethambutol; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Hepatic; Typhlitis | 2007 |
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical | 2007 |
Mycobacterium fortuitum-induced persistent parotitis: successful therapy with clarithromycin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Female; Humans; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Parotitis | 2007 |
Evaluation of the broth microdilution method using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing.
Topics: Anti-Bacterial Agents; Cefoxitin; Chemistry, Pharmaceutical; Ciprofloxacin; Clarithromycin; Colorimetry; Drug Resistance, Bacterial; Korea; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium fortuitum; Tetrazolium Salts | 2007 |
In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay.
Topics: Agar; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Reproducibility of Results; Species Specificity; Tetrazolium Salts; Time Factors | 2008 |
Legionella pneumonia caused by Legionella pneumophila serogroup 2: second case report in Japan.
Topics: Anti-Infective Agents; Antigens, Bacterial; Ciprofloxacin; Clarithromycin; Humans; Japan; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Serotyping; Treatment Outcome | 2008 |
The intracellular accumulation of phagocytic and epithelial cells and the inhibitory effect on Chlamydophila (Chlamydia) pneumoniae of telithromycin and comparator antimicrobials.
Topics: Anti-Bacterial Agents; Cell Line; Chlamydophila pneumoniae; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Minocycline; Phagocytes | 2008 |
Postoperative Mycobacterium abscessus nodular conjunctivitis.
Topics: Aged; Anti-Bacterial Agents; Cataract Extraction; Ciprofloxacin; Clarithromycin; Conjunctivitis; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium Infections, Nontuberculous; Postoperative Complications; Recurrence | 2008 |
[Severe course of a rare non-tuberculous Mycobacteriosis (M. haemophilum) of the hand - case report and strategic comments].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Debridement; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hand; Humans; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Rifabutin; Synovitis; Time Factors; Treatment Outcome | 2008 |
Bilateral sporotrichoid lymphocutaneous dermatosis in a drug abuser: case report and review of the literature.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Users; Female; Humans; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Pain; Polymerase Chain Reaction; Skin Diseases | 2008 |
Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Peptic Ulcer; Polymerase Chain Reaction; Stomach; Tetracycline | 2009 |
Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.
Topics: Animals; Anti-Infective Agents; Biofilms; Ciprofloxacin; Clarithromycin; Humans; Lactoferrin; Microbial Sensitivity Tests; Minocycline; Porphyromonas gingivalis; Prevotella intermedia | 2009 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
Disseminated infection with Bartonella henselae in a lung transplant recipient.
Topics: Adult; Anti-Bacterial Agents; Bartonella henselae; Cat-Scratch Disease; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Lung; Lung Transplantation; Magnetic Resonance Imaging; Rifampin; Treatment Outcome | 2009 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionellosis; Microbial Sensitivity Tests; Naphthyridines | 2010 |
[A cutaneous infection by Mycobacterium chelonae in a patient with rheumatoid arthritis].
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Ciprofloxacin; Clarithromycin; Drug Combinations; Female; Glucosamine; Humans; Immunosuppressive Agents; Leg; Methotrexate; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Sulfasalazine; Tuberculosis, Cutaneous | 2010 |
Phenotypic and genetic characterization of antimicrobial profiles of Helicobacter pylori strains in Cuba.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Cuba; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sex Factors; Species Specificity; Tetracycline; Young Adult | 2010 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Giardia lamblia; Giardiasis; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Immunoblotting; Lymphatic Diseases; Male; Metronidazole; Omeprazole | 2010 |
Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment.
Topics: Acupuncture Therapy; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Skin Diseases, Bacterial | 2011 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium; Nontuberculous Mycobacteria; Species Specificity | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Portugal; Prospective Studies; Tetracycline | 2011 |
Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
Topics: Adult; Aged; Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Republic of Korea; Tetracycline | 2012 |
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Contact Tracing; Drug Therapy, Combination; Humans; Male; Mycobacterium haemophilum; Mycobacterium Infections; Rifampin; Skin Diseases, Bacterial; Tattooing; Treatment Outcome; Washington | 2011 |
Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.
Topics: Adult; Aged; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin.
Topics: Adult; Allergens; Ciprofloxacin; Clarithromycin; Female; Humans; Male; Middle Aged; Regional Blood Flow; Rifampin; Skin Test End-Point Titration; Young Adult | 2012 |
Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cluster Analysis; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Helicobacter; Helicobacter Infections; Hospitals; Humans; Japan; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Mutation; RNA, Ribosomal, 23S | 2012 |
Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lithuania; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Tetracycline | 2013 |
Helicobacter cinaedi and Helicobacter fennelliae transmission in a hospital from 2008 to 2012.
Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cluster Analysis; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Helicobacter; Helicobacter Infections; Hospitals; Humans; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing | 2013 |
Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; China; Chromatography, Gas; Ciprofloxacin; Clarithromycin; Imipenem; Microbial Sensitivity Tests; Mycobacterium; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique | 2013 |
The potential for antimicrobials to adversely affect mental state.
Topics: Anti-Infective Agents; Bipolar Disorder; Ciprofloxacin; Clarithromycin; Commitment of Mentally Ill; Confusion; Female; Humans; Middle Aged; Organotechnetium Compounds | 2013 |
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Cohort Studies; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Treatment Outcome | 2013 |
Infection with Mycobacterium fortuitum during acupoint embedding therapy.
Topics: Acupuncture Points; Acupuncture Therapy; Adult; Biopsy, Needle; Cheek; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunohistochemistry; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Rare Diseases; Severity of Illness Index; Treatment Outcome | 2014 |
Environmental risk assessment of selected pharmaceuticals in Turkey.
Topics: 1-Octanol; Acetaminophen; Adsorption; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzalkonium Compounds; Cefuroxime; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Naproxen; Pharmaceutical Preparations; Risk Assessment; Sewage; Turkey; Water; Water Pollutants, Chemical | 2014 |
Mycobacterium fortuitum infection arising in a new tattoo.
Topics: Adult; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clarithromycin; Cosmetic Techniques; Drug Therapy, Combination; Humans; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Tattooing; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium; Mycobacterium Infections; Pyrazinamide; Radiography | 2014 |
Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Drug Prescriptions; Female; Glipizide; Glyburide; Health Care Costs; Humans; Hypoglycemia; Hypoglycemic Agents; Levofloxacin; Logistic Models; Male; Medicare; Metronidazole; Morbidity; Odds Ratio; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Texas; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2014 |
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device].
Topics: Aged; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheterization, Central Venous; Ciprofloxacin; Clarithromycin; Humans; Lymphoma, Non-Hodgkin; Male; Mycobacterium; Mycobacterium Infections | 2014 |
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; beta-Lactamase Inhibitors; Cardiovascular Diseases; Ciprofloxacin; Clarithromycin; Comorbidity; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Moxifloxacin; Risk; Taiwan | 2015 |
Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antitubercular; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Withholding Treatment | 2015 |
Catheter related line sepsis resulting from Mycobacterium chelonae infection in an immunocompromised host.
Topics: Adult; Catheter-Related Infections; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ovarian Neoplasms; Sepsis; Vascular Access Devices | 2015 |
Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria.
Topics: Acetylcysteine; Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clarithromycin; Microbial Sensitivity Tests; Microscopy, Confocal; Mycobacterium; Polysorbates | 2016 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult | 2016 |
Multiple drug allergy: A case of anaphylaxis to levofloxacin but tolerance to ciprofloxacin.
Topics: Adolescent; Amoxicillin; Anaphylaxis; Ciprofloxacin; Clarithromycin; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Levofloxacin; Male; Tonsillitis | 2016 |
A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Arthritis, Infectious; Bendamustine Hydrochloride; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mycoplasma Infections; Mycoplasma salivarium; Rituximab | 2016 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella | 2016 |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
Topics: Anti-Bacterial Agents; Biopsy; Cellulitis; Ciprofloxacin; Clarithromycin; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lower Extremity; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Rifabutin; Tacrolimus; Unrelated Donors | 2017 |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline | 2017 |
Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.
Topics: Adsorption; Anti-Bacterial Agents; Antidepressive Agents; Azithromycin; Ciprofloxacin; Citalopram; Clarithromycin; Environmental Monitoring; Sewage; Slovakia; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical | 2017 |
Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Population Surveillance; Tertiary Care Centers; Tobramycin; Young Adult | 2017 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Female; Humans; Lupus Erythematosus, Systemic; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pregnancy; Treatment Outcome | 2018 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Czech Republic; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough; Young Adult | 2017 |
Enhanced adsorption of ionizable antibiotics on activated carbon fiber under electrochemical assistance in continuous-flow modes.
Topics: Adsorption; Anti-Bacterial Agents; Carbon; Carbon Fiber; Ciprofloxacin; Clarithromycin; Electrochemical Techniques; Sulfadimethoxine; Water Pollutants, Chemical; Water Purification | 2018 |
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Trichechus inunguis | 2018 |
Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
Topics: Adult; Algeria; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Tetracycline | 2018 |
Oxidative stress responses and cellular energy allocation changes in microalgae following exposure to widely used human antibiotics.
Topics: Animals; Anti-Bacterial Agents; Catalase; Chlorophyta; Ciprofloxacin; Clarithromycin; Energy Metabolism; Environmental Exposure; Erythromycin; Humans; Lipid Peroxidation; Microalgae; Oxidative Stress; Sulfamethoxazole; Superoxide Dismutase; Water Pollutants, Chemical | 2018 |
Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus.
Topics: Amikacin; Anti-Bacterial Agents; Biological Transport; Ciprofloxacin; Clarithromycin; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Pyrrolidines; Verapamil | 2019 |
Bacterial profile and antimicrobial susceptibility patterns in chronic suppurative otitis media at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Ciprofloxacin; Clarithromycin; Ethiopia; Hospitals, Special; Hospitals, University; Humans; Microbial Sensitivity Tests; Norfloxacin; Otitis Media, Suppurative; Proteus mirabilis; Staphylococcus aureus | 2019 |
Hypercalcaemia secondary to disseminated Mycobacterium abscessus and Mycobacterium fortuitum.
Topics: Aged; Anti-Bacterial Agents; Antibodies; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Granuloma; Humans; Hypercalcemia; Interferons; Liver; Macrophage Colony-Stimulating Factor; Mycobacterium abscessus; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Singapore | 2019 |
Histological changes in refractory Helicobacter pylori infection and its relationship with increased levels of resistance to antibiotics and therapeutic regimens: one-year follow-up.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Biopsy; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histological Techniques; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Stomach | 2020 |
Environmental Risk and Risk of Resistance Selection Due to Antimicrobials' Occurrence in Two Polish Wastewater Treatment Plants and Receiving Surface Water.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Sewage; Sulfamethoxazole; Tandem Mass Spectrometry; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2020 |
Disseminated Mycobacterium simiae infection in a patient with adult-onset immunodeficiency due to anti-interferon-gamma antibodies - a case report.
Topics: Autoantibodies; Ciprofloxacin; Clarithromycin; Humans; Image-Guided Biopsy; Immunologic Deficiency Syndromes; Interferon-gamma; Lymph Nodes; Lymphadenopathy; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Positron-Emission Tomography; Sri Lanka; Young Adult | 2020 |
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Comorbidity; Crohn Disease; Enterobacteriaceae Infections; Female; Hafnia alvei; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Rare Diseases; Treatment Outcome; Young Adult | 2020 |
Difference in drug susceptibility distribution and clinical characteristics between
Topics: Adult; Aged; Anti-Bacterial Agents; China; Ciprofloxacin; Clarithromycin; Cough; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Lung; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography; Sputum | 2021 |
Photodegradation of Ciprofloxacin, Clarithromycin and Trimethoprim: Influence of pH and Humic Acids.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Darkness; Half-Life; Humic Substances; Hydrogen-Ion Concentration; Kinetics; Light; Trimethoprim | 2021 |
Antibiotics in the Basque coast (N Spain): Occurrence in waste and receiving waters, and risk assessment (2017-2020).
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; COVID-19; Ecosystem; Environmental Monitoring; Fluoroquinolones; Humans; Penicillins; Risk Assessment; Spain; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2022 |
Predicting selection for antimicrobial resistance in UK wastewater and aquatic environments: Ciprofloxacin poses a significant risk.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; United Kingdom; Wastewater; Water Pollutants, Chemical | 2022 |
Design, synthesis and evaluation of oxazolopyridinone derivatives as quorum sensing inhibitors.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Pseudomonas aeruginosa; Pyocyanine; Quorum Sensing | 2023 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Direct toxicity of six antibiotics on soil bacterial communities affected by the addition of bio-adsorbents.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biomass; Ciprofloxacin; Clarithromycin; Soil; Soil Pollutants; Trimethoprim | 2023 |
Seasonal analysis of commonly prescribed antibiotics in Istanbul city.
Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Seasons; Sewage; Solid Phase Extraction; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2023 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
Evaluation of ciprofloxacin (CIP) and clarithromycin (CLA) adsorption with weathered PVC microplastics.
Topics: Adsorption; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Hydrogen-Ion Concentration; Kinetics; Microplastics; Plastics; Spectroscopy, Fourier Transform Infrared; Thermodynamics; Water Pollutants, Chemical | 2023 |
Antibiotic susceptibility pattern of Portuguese environmental Legionella isolates.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Doxycycline; Fluoroquinolones; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Portugal | 2023 |